A Practitioner's Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel.
Initiation
Insulin distress
Intensification
Motivational interviewing
Practitioner’s tool kit
Pre-initiation
Titration
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
19
11
2019
pubmed:
26
1
2020
medline:
26
1
2020
entrez:
26
1
2020
Statut:
ppublish
Résumé
To develop an evidence-based expert group opinion on the role of insulin motivation to overcome insulin distress during different stages of insulin therapy and to propose a practitioner's toolkit for insulin motivation in the management of diabetes mellitus (DM). Insulin distress, an emotional response of the patient to the suggested use of insulin, acts as a major barrier to insulin therapy in the management of DM. Addressing patient-, physician- and drug-related factors is important to overcome insulin distress. Strengthening of communication between physicians and patients with diabetes and enhancing the patients' coping skills are prerequisites to create a sense of comfort with the use of insulin. Insulin motivation is key to achieving targeted goals in diabetes care. A group of endocrinologists came together at an international meeting held in India to develop tool kits that would aid a practitioner in implementing insulin motivation strategies at different stages of the journey through insulin therapy, including pre-initiation, initiation, titration and intensification. During the meeting, emphasis was placed on the challenges and limitations faced by both physicians and patients with diabetes during each stage of the journey through insulinization. After review of evidence and discussions, the expert group provided recommendations on strategies for improved insulin acceptance, empowering behavior change in patients with DM, approaches for motivating patients to initiate and maintain insulin therapy and best practices for insulin motivation at the pre-initiation, initiation, titration and intensification stages of insulin therapy. In the management of DM, bringing in positive behavioral change by motivating the patient to improve treatment adherence helps overcome insulin distress and achieve treatment goals.
Sections du résumé
AIM
OBJECTIVE
To develop an evidence-based expert group opinion on the role of insulin motivation to overcome insulin distress during different stages of insulin therapy and to propose a practitioner's toolkit for insulin motivation in the management of diabetes mellitus (DM).
BACKGROUND
BACKGROUND
Insulin distress, an emotional response of the patient to the suggested use of insulin, acts as a major barrier to insulin therapy in the management of DM. Addressing patient-, physician- and drug-related factors is important to overcome insulin distress. Strengthening of communication between physicians and patients with diabetes and enhancing the patients' coping skills are prerequisites to create a sense of comfort with the use of insulin. Insulin motivation is key to achieving targeted goals in diabetes care. A group of endocrinologists came together at an international meeting held in India to develop tool kits that would aid a practitioner in implementing insulin motivation strategies at different stages of the journey through insulin therapy, including pre-initiation, initiation, titration and intensification. During the meeting, emphasis was placed on the challenges and limitations faced by both physicians and patients with diabetes during each stage of the journey through insulinization.
REVIEW RESULTS
RESULTS
After review of evidence and discussions, the expert group provided recommendations on strategies for improved insulin acceptance, empowering behavior change in patients with DM, approaches for motivating patients to initiate and maintain insulin therapy and best practices for insulin motivation at the pre-initiation, initiation, titration and intensification stages of insulin therapy.
CONCLUSIONS
CONCLUSIONS
In the management of DM, bringing in positive behavioral change by motivating the patient to improve treatment adherence helps overcome insulin distress and achieve treatment goals.
Identifiants
pubmed: 31981212
doi: 10.1007/s13300-020-00764-7
pii: 10.1007/s13300-020-00764-7
pmc: PMC7048897
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
585-606Subventions
Organisme : Sanofi India
ID : -
Références
Qual Life Res. 2009 Feb;18(1):23-32
pubmed: 19039679
Hong Kong Med J. 2016 Aug;22(4):304-5
pubmed: 27511968
Curr Med Res Opin. 2012 Dec;28(12):1933-46
pubmed: 23150949
J Gen Intern Med. 2016 Aug;31(8):929-40
pubmed: 27160414
Diabetes Care. 2015 Jan;38(1):140-9
pubmed: 25538310
Diabetes Technol Ther. 2012 Jul;14(7):630-4
pubmed: 22524548
Arch Intern Med. 2003 Jan 13;163(1):83-90
pubmed: 12523921
Diabetes Care. 2019 Jan;42(Suppl 1):S4-S6
pubmed: 30559226
Diabet Med. 2005 Apr;22(4):415-20
pubmed: 15787666
J Diabetes Sci Technol. 2010 May 01;4(3):661-5
pubmed: 20513334
Diabet Med. 2012 May;29(5):682-9
pubmed: 22313123
Clinicoecon Outcomes Res. 2013 Oct 03;5:497-505
pubmed: 24124384
Diabetes Care. 2013 Feb;36(2):463-70
pubmed: 23349150
J Diabetes Sci Technol. 2010 May 01;4(3):522-31
pubmed: 20513316
BMJ Open. 2018 Nov 28;8(11):e020062
pubmed: 30498035
J Basic Clin Pharm. 2013 Dec;5(1):15-8
pubmed: 24808683
Acad Med. 2011 Mar;86(3):359-64
pubmed: 21248604
Health Qual Life Outcomes. 2007 Dec 20;5:69
pubmed: 18096074
Diabetes Manag (Lond). 2015;5(6):499-510
pubmed: 30100925
PLoS One. 2015 Sep 03;10(9):e0136759
pubmed: 26336088
J Diabetes Sci Technol. 2009 May 01;3(3):492-9
pubmed: 20144287
Diabetes Care. 2014 Jun;37(6):1499-508
pubmed: 24855154
Diabetes Care. 1997 May;20(5):760-6
pubmed: 9135939
Diabetes Care. 2007 Jun;30(6):1390-5
pubmed: 17351283
J Multidiscip Healthc. 2014 Jul 02;7:267-82
pubmed: 25061317
Eur Endocrinol. 2018 Sep;14(2):18-19
pubmed: 30349589
West J Nurs Res. 2015 May;37(5):566-80
pubmed: 24733233
Diabetes Care. 2016 Dec;39(12):2126-2140
pubmed: 27879358
Adv Ther. 2017 Sep;34(9):2083-2092
pubmed: 28779282
Diabetes Metab Syndr Obes. 2017 Dec 15;10:521-532
pubmed: 29276400
Int J Clin Pract. 2017 Aug;71(8):
pubmed: 28735508
Endocr Pract. 2015 Feb;21(2):143-57
pubmed: 25297660
Diabetes Obes Metab. 2018 Mar;20(3):488-496
pubmed: 29053215
Diabetes Care. 2005 Oct;28(10):2543-5
pubmed: 16186296
Diabetes Care. 2010 Apr;33(4):733-5
pubmed: 20086256